ESTRO PT 2018

Aim 3: Clinical Risk Prediction • Specific Aim 3: To develop a risk prediction algorithm using biomarkers, echo data, and clinical variables to identify patients at increased risk of RT cardiotoxicity. – Hypothesis: Risk scores integrating circulating biomarkers, imaging parameters, and clinical variables are robust predictors of subsequent RT cardiotoxicity.

Aim 2: Echo

Aim 1: Biomarkers

Clinical

Aim 3: Predict High CV Risk